The FMR1 Gene Fragile X Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the FMR1 gene, which are indicative of Fragile X Syndrome (FXS). This condition is a genetic disorder that causes a range of developmental problems including learning disabilities and cognitive impairment. The test is particularly crucial for individuals with a family history of FXS or those showing symptoms of the disorder. By analyzing a sample of the individual's DNA, the test identifies variations in the CGG repeat length within the FMR1 gene, which are responsible for causing the syndrome. The cost of the FMR1 Gene Fragile X Syndrome Genetic Test at DNA Labs UAE is 4400 AED, making it a valuable resource for families seeking answers about this inheritable condition. Early diagnosis through this test can lead to better management and support for those affected by Fragile X Syndrome.
The FMR1 Gene Fragile X Tremor Ataxia Syndrome (FXTAS) Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the FMR1 gene. This gene is crucial because alterations in its structure are associated with Fragile X Tremor Ataxia Syndrome, a condition that affects the nervous system, leading to symptoms such as tremors, problems with movement and balance (ataxia), and cognitive impairments. The test is particularly important for individuals who have a family history of FXTAS or related disorders, as it can provide valuable information for managing and understanding the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the FMR1 gene. Conducting this test at DNA Labs UAE ensures that patients receive reliable results, thanks to the lab's commitment to high-quality standards and its use of advanced genetic testing technologies.
The FXN Gene Friedreich Ataxia Genetic Test is a specialized diagnostic tool used to identify mutations in the FXN gene, which are responsible for Friedreich's ataxia, a rare inherited disease. This condition affects the nervous system and causes movement problems, and it can also lead to heart disease. The test is crucial for early diagnosis, which can aid in managing symptoms and planning for the necessary care and interventions.
Performed at DNA Labs UAE, the test involves analyzing a sample of the patient's DNA to look for specific genetic alterations associated with the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the presence of the FXN gene mutations. This test is an important step for families with a history of Friedreich's ataxia, offering them crucial information for genetic counseling and decision-making regarding their health and future.
The FLNA Gene Frontometaphyseal Dysplasia Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the FLNA gene, which are responsible for Frontometaphyseal Dysplasia (FMD). FMD is a rare genetic disorder characterized by abnormalities in the development of the skeletal system and the muscles, leading to distinctive facial features, skeletal malformations, and other systemic complications. The FLNA gene plays a crucial role in cell structure and movement, and mutations in this gene can disrupt the normal development of bones and other tissues.
This genetic test involves analyzing the patient's DNA to detect mutations in the FLNA gene that are indicative of Frontometaphyseal Dysplasia. It is a critical tool for confirming a diagnosis of FMD, enabling appropriate medical management and genetic counseling for affected individuals and their families.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the FLNA Gene Frontometaphyseal Dysplasia Genetic Test is 4400 AED. This comprehensive test is conducted under stringent quality control measures to ensure accurate and reliable results, providing essential information for the diagnosis and management of Frontometaphyseal Dysplasia.
The "ROBO3 Gene Gaze Palsy Horizontal with Progressive Scoliosis Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the ROBO3 gene. These mutations are linked to a rare neurological disorder characterized by horizontal gaze palsy and progressive scoliosis, a condition where patients are unable to move their eyes horizontally and develop a sideways curvature of the spine that worsens over time. This genetic test plays a crucial role in the early detection and management of the disorder, enabling healthcare professionals to devise appropriate treatment plans and offer genetic counseling to affected families. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify the genetic anomaly associated with this condition.
The "KCNMA1 Gene Generalized Epilepsy and Paroxysmal Dyskinesia Genetic Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the KCNMA1 gene. Mutations in this gene are known to be associated with a range of neurological conditions, including generalized epilepsy and paroxysmal dyskinesia. These disorders are characterized by recurrent seizures and involuntary movements, respectively, which can significantly impact an individual's quality of life.
This genetic test involves analyzing the patient's DNA to detect abnormalities in the KCNMA1 gene, providing crucial information for accurate diagnosis and tailored treatment planning. It is particularly beneficial for individuals who exhibit symptoms of these conditions or have a family history of related neurological disorders.
The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to perform the analysis. Conducted at DNA Labs UAE, a leading facility in genetic testing, patients can expect high-quality service and reliable results. This test represents a significant step forward in the personalized treatment of neurological conditions, offering hope to many individuals and families affected by these challenging disorders.
The SCN1A gene Generalized Epilepsy with Febrile Seizures Plus Type 2 (GEFS+2) genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the SCN1A gene. This gene plays a critical role in the functioning of brain cells by coding for a subunit of the sodium channel, which is essential for the transmission of electrical signals in the nervous system. Mutations in the SCN1A gene are associated with various epilepsy syndromes, including GEFS+2, which is characterized by a spectrum of seizure types that range from mild febrile seizures to more severe forms of epilepsy.
The test is particularly important for individuals who have a family history of GEFS+2 or exhibit symptoms suggestive of this condition. By analyzing a sample of the patient's DNA, the test can confirm the presence of mutations in the SCN1A gene, providing valuable information for diagnosis, management, and treatment planning. This can also offer insights into the risk of epilepsy in family members and the likelihood of passing the condition to offspring.
The cost of the SCN1A gene Generalized Epilepsy with Febrile Seizures Plus Type 2 genetic test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the specific expertise required to interpret the results, it represents a critical investment in the accurate diagnosis and tailored management of epilepsy syndromes associated with SCN1A mutations.
The SCN9A Gene Generalized Epilepsy with Febrile Seizures Plus Type 7 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the SCN9A gene, which have been linked to the development of Generalized Epilepsy with Febrile Seizures Plus (GEFS+) Type 7, a complex and rare epileptic disorder. GEFS+ Type 7 is characterized by a broad spectrum of seizure types that usually begin in infancy or early childhood and may persist into adulthood. These seizures are often triggered by fever but can occur without it as the individual ages.
The SCN9A gene plays a critical role in the functioning of sodium channels in the brain, which are essential for the transmission of electrical signals in the nervous system. Mutations in this gene can disrupt the normal flow of electrical signals, leading to the development of seizures.
The test involves a detailed analysis of the individual's DNA to detect any abnormalities or mutations in the SCN9A gene that might be responsible for the condition. This genetic testing is crucial for the accurate diagnosis of GEFS+ Type 7, allowing for personalized treatment plans that can significantly improve the quality of life for affected individuals.
Administered by the experienced professionals at DNA Labs UAE, the test is conducted with the utmost precision and care, ensuring reliable results for patients and their families.
The STX1B gene generalized epilepsy with febrile seizures plus type 9 genetic test is a specialized diagnostic tool used to identify mutations in the STX1B gene, which have been associated with the development of generalized epilepsy with febrile seizures plus (GEFS+) type 9. This condition is a form of epilepsy that typically manifests in childhood and is characterized by the occurrence of febrile seizures, which are seizures accompanied by fever, as well as a spectrum of other seizure types as the individual ages. The identification of a mutation in the STX1B gene can help in confirming a diagnosis, guiding treatment options, and providing information on the risk of inheritance for family members.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, which reflects the comprehensive analysis and the specialized technology required to accurately identify mutations in the STX1B gene. By opting for this test, patients and their families can gain valuable insights into the genetic basis of the condition, enabling more personalized and effective management of the disorder.
The CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to identify mutations in the CHRNA2 gene, which have been linked to epilepsy nocturnal frontal lobe type 4 (ENFL4). ENFL4 is a rare form of epilepsy characterized by nocturnal seizures with frontal lobe origin, affecting individuals during sleep. The CHRNA2 gene plays a crucial role in the proper functioning of neuronal nicotinic acetylcholine receptors, which are essential for normal neurological activity. Mutations in this gene can disrupt normal brain activity, leading to the development of epilepsy.
The test is conducted through a detailed analysis of the patient's DNA, extracted from a blood sample, to detect any genetic anomalies in the CHRNA2 gene. This genetic testing is pivotal for individuals with a family history of ENFL4 or those exhibiting symptoms, as it provides a definitive diagnosis, enabling targeted treatment and management of the condition.
The cost of the CHRNA2 Gene Epilepsy Nocturnal Frontal Lobe Type 4 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, covering the expenses of the genetic analysis, the expertise of the medical professionals involved, and the use of advanced laboratory technology to ensure accurate results. Undergoing this test at DNA Labs UAE offers patients access to state-of-the-art genetic testing services, with reliable results that can significantly impact the management and understanding of epilepsy nocturnal frontal lobe type 4.
